AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
19 Aug 1999 09:00 AM
RNS
Injunction Upheld
03 Aug 1999 07:34 AM
RNS
First Interim Dividend
03 Aug 1999 07:33 AM
RNS
Interim Results - Part 3
03 Aug 1999 07:32 AM
RNS
Interim Results - Part 2
03 Aug 1999 07:31 AM
RNS
Interim Results - Part 1

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.

It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.

Astra Zeneca share price launched at 605p in 1993.

UK 100

Latest directors dealings